Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Appointed COO
|
|
Immune Therapeutics, Inc. (IMUN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/20/2023 |
8-K
| Quarterly results |
| 03/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 01/03/2023 |
8-K
| Quarterly results |
| 11/09/2022 |
8-K
| Quarterly results |
| 10/12/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 09/27/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors ORLANDO, FL, Sept. 27, 2022 — Immune Therapeutics, Inc . , a specialty pharmaceutical company involved in the acquisition, development, and commercialization of pharmaceutical and biotechnology products with a well-defined path to market, today announced the appointment of Louis Salomonsky to the Company’ s Board of Directors. “On behalf of the Board and leadership of Immune, I would like to welcome Louis to Immune’ s Board,” said Dr. Stephen Wilson, CEO of Immune. “Mr. Salomonsky’ s operational leadership, as well as his track record of deal-making and financial acumen, will be instrumental in moving our programs forward.” Commenting on his appointment, Mr. Salomonsky said, “I am excited to join Immune’ s Board to ..." |
|
| 08/04/2022 |
8-K
| Quarterly results |
| 07/22/2022 |
8-K
| Quarterly results |
| 07/07/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
8-K
| Quarterly results |
| 06/02/2021 |
8-K
| Quarterly results |
| 01/26/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/22/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/17/2020 |
8-K
| Quarterly results |
| 07/27/2020 |
8-K
| Quarterly results |
| 05/14/2020 |
8-K
| Other Events |
| 05/05/2020 |
8-K
| Quarterly results |
| 04/16/2020 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 03/20/2020 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 02/19/2020 |
8-K
| Quarterly results |
| 10/31/2019 |
8-K
| Quarterly results |
| 09/25/2019 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 07/01/2019 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 01/08/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/11/2018 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial State... |
| 05/22/2018 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement |
| 04/27/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/28/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/29/2017 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 12/01/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/02/2017 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 09/08/2017 |
8-K
| Quarterly results |
| 08/25/2017 |
8-K
| Quarterly results |
| 06/09/2017 |
8-K
| Form 8-K - Current report |
|
|
|